Our latest article “Strict Procedures vs Urgent Needs: Is it possible to be equal to the occasion?” by Nihan Bacanak, Can Aksoy ve Bengüsu Güvendi is published on Lexology.
As known, pharmaceutical products for human use can in principle only be placed on the market upon obtaining a licence for the specified indications for which the product is allowed to be used. On the other hand, as experienced during the COVID-19 pandemic, not being able to access pharmaceutical products particularly in cases of emergency where a licensed product is unavailable can lead to aggrievements and the lengthiness of the process of obtaining a licence for a pharmaceutical product can cause additional problems. Hence it is of utmost importance to properly set a balance between satisfying the urgent needs of patients in an efficient manner and safely placing the products on the market. Various methods enabling patients to access unlicensed products are available under Turkish law. Amongst these methods which are briefly described below, named patient programme and off-label use have enabled rapid actions to be taken in particular during the COVID-19 pandemic.
You may reach the article here.
Share
Related persons
You can contact us for detailed information.

Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
24 April 2026
Turkish competition board fines seventeen pharmaceutical companies for no-poach agreements and wage data exchange
On 8 April 2026, the Turkish Competition Board published its decision dated 11 September 2025 and numbered 25-34/810-474 concluding a broad…
22 April 2026
Fintech in Türkiye 2026 – law and practice
The fintech sector in Türkiye has been developing steadily over the past several years, with growth accelerating significantly in recent…
22 April 2026
Fintech in Türkiye 2026 – trends and developments
The fintech sector in Türkiye has been developing steadily over the past several years, with growth accelerating significantly in recent…
20 April 2026
Bill on digital copyright and online news content
Following the submission of the Digital Copyright Bill (“Digital Copyright Bill“) to the Presidency of the Grand National Assembly of…
15 April 2026
Just cause termination in disciplinary investigations under Turkish law
Heightened regulatory expectations and evolving corporate governance standards have placed internal investigations at the centre of…
13 April 2026
Recent developments in healthcare legislation – Issue 2026/1
The Guideline on Trust Practices in Clinical Trial Applications published by the Turkish Medicines and Medical Devices Agency was updated…